As part of Cytel’s webinar series on “Advancing Innovation in Clinical Trial Design”, we have seen how the drug development process has been optimized in recent years. The traditional clinical trial model has faced significant challenges due to increased competition. In the past 2 years, the outbreak of COVID-19 also imposed a disruptive impact onto the sustainability of the clinical research ecosystem that steers pioneer efforts in advancing digital trials. The digital trial leverages the digital applications and solutions (such as real world data analytics, insights, sensors, apps) to improve clinical design from start-up to closure, reduce screening failures with digital feasibility and screening, improve participant access and engagement with virtual communication tools, enhance operation quality and efficiency with reduced site visits via remote monitoring, and streamline data collection process with e-Source. The integrated digital solutions also enable the decentralized trial operation model to successfully harness digital methods and the myriad benefits of such technologies for clinical research.
During this webinar Luyan Dai will share the recent development of the digital applications and pilot implementation in China.
